Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Matas Lecture. Heparin--controversies and misconceptions

F W Blaisdell1

  • 1Department of Surgery, University of California, Davis, Medical Center, Sacramento 95817-2282, USA.

Cardiovascular Surgery (London, England)
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular surgeon Edwin J. Wylie, MD (1918-1982), pioneer and visionary.

Vascular surgery·2001
Same author

Natural history of congenital arteriovenous fistula.

Cardiovascular surgery (London, England)·1999
Same author

Our surgical heritage. The Civil War.

Bulletin of the American College of Surgeons·1999
Same author

Low-dose heparin thromboembolism prophylaxis.

Archives of surgery (Chicago, Ill. : 1960)·1996
Same author

Ligation and extraanatomic arterial reconstruction for the treatment of aneurysms of the abdominal aorta.

Journal of vascular surgery·1994
Same author

The current status of intraosseous infusion.

Journal of the American College of Surgeons·1994
Same journal

Evaluation of outcomes from deep sternal wound complications.

Cardiovascular surgery (London, England)·2003
Same journal

Traumatic bilateral renal artery thrombosis: case report and review of the literature.

Cardiovascular surgery (London, England)·2003
Same journal

Intracavitary cardiac hydatid cyst.

Cardiovascular surgery (London, England)·2003
Same journal

Coil embolization of an inferior pancreaticoduodenal artery aneurysm associated with celiac artery occlusion.

Cardiovascular surgery (London, England)·2003
Same journal

Conservative vs. invasive treatment of aortocoronary saphenous vein graft aneurysms: Treatment algorithm based upon a large series.

Cardiovascular surgery (London, England)·2003
Same journal

Classification of left main coronary obstruction--feasibility of surgical angioplasty and survival after coronary artery bypass surgery.

Cardiovascular surgery (London, England)·2003
See all related articles

Current heparin therapy guidelines may not be clinically relevant. High initial heparin doses are crucial for controlling life-threatening clotting, with clinical assessment guiding treatment effectiveness.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pharmacology

Background:

  • Existing guidelines for heparin therapy are based on experimental data lacking clinical relevance.
  • The clinical efficacy of heparin anticoagulation is challenged by factors influencing clotting and refractory responses.

Discussion:

  • Current laboratory tests cannot accurately monitor heparin's anticoagulant effects.
  • Bleeding risk is associated with clinical factors and platelet function, not heparin levels.
  • Initial high-dose heparin is necessary to control clotting effectively, maximizing benefits and minimizing risks.

Key Insights:

  • Heparin's clinical effectiveness is questionable due to outdated experimental foundations.
  • Accurate monitoring of heparin anticoagulation is not feasible with current laboratory tests.

Related Experiment Videos

  • Clinical assessment of patient response is paramount for effective heparin therapy.

    • Outlook:

    • Re-evaluation of heparin therapy protocols based on clinical evidence is needed.
    • Future research should focus on developing reliable methods for monitoring heparin efficacy and safety.
    • Optimizing heparin dosing strategies based on individual patient risk factors and clinical outcomes is essential.